Advances and avenues in the development of novel carriers for bioactives /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London :
Academic Press,
2020.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
- Copyright Page
- Contents
- List of Contributors
- 1 Challenges and need of delivery carriers for bioactives and biological agents: an introduction
- 1.1 Introduction
- 1.2 Bioactives and biological agents
- 1.2.1 Phytoactives
- 1.2.2 Bioactive peptides
- 1.2.3 Bioactive lipids
- 1.2.4 Micronutrients
- 1.3 Therapeutic significance of bioactives
- 1.4 Need and challenges of delivery carriers for bioactives
- 1.4.1 Challenges in phytoactive delivery
- 1.4.2 Challenges in protein and peptides delivery
- 1.4.2.1 Chemical modification
- 1.4.2.2 Delivery system
- 1.4.3 Challenges in vitamins delivery
- 1.5 Application of nanotechnology for the delivery of bioactives
- 1.5.1 Nanodelivery carriers for phytoactives or phytomedicines
- 1.5.1.1 Liposomes
- 1.5.1.1.1 Anticancer phytoactives
- 1.5.1.1.2 Antimicrobial phytomedicines
- 1.5.1.2 Niosomes
- 1.5.1.2.1 Antitumor phytoactive
- 1.5.1.2.2 Antiinflammatory phytoactive
- 1.5.1.3 Solid lipid nanoparticles
- 1.5.1.4 Polymeric nanoparticles
- 1.5.1.5 Metal-based nanoparticles
- 1.5.2 Nanodelivery carrier for bioactive peptides/protein
- 1.5.2.1 Vaccines delivery
- 1.5.2.2 Hormone delivery: insulin
- 1.5.2.3 Enzyme delivery: digestive enzymes
- 1.5.2.4 Antimicrobial delivery
- 1.6 Toxicity and safety concern
- 1.7 Conclusion
- Declaration of interest
- References
- 2 Natural product-based nanomedicine: polymeric nanoparticles as delivery cargoes of food bioactives and nutraceuticals for ...
- 2.1 Problems with anticancer treatment
- 2.1.1 Tumor size
- 2.1.2 Toxicity
- 2.1.3 Hair loss
- 2.1.4 Nausea and vomiting
- 2.1.5 Leukopenia
- 2.1.6 Mucositis
- 2.1.7 Drug resistance
- 2.1.8 Tumor stem cells
- 2.2 Overcoming drug resistance
- 2.3 Bioactive molecules found in functional foods and nutraceuticals: antitumor activity and chemotherapy treatment improvement
- 2.3.1 Caffeine
- 2.3.2 Catechins
- 2.3.3 Theobromine
- 2.3.4 Capsaicin
- 2.3.5 Sulforaphane
- 2.3.6 Apigenin
- 2.3.7 Resveratrol
- 2.4 Nanotechnology: an alternative way to improve natural products antitumor capacity through better molecules delivery
- 2.5 Physiological barriers: challenges for natural products target delivery
- 2.6 Polymeric nanoparticles: use in the oncological area for the delivery of bioactive molecules
- References
- Further reading
- 3 The promising expedition of the delivery systems for monoclonal antibodies
- 3.1 Introduction
- 3.2 Monoclonal antibodies
- 3.2.1 Origins/types of monoclonal antibodies
- 3.2.2 Production methodologies
- 3.2.3 Functions and therapeutic applications of monoclonal antibodies
- 3.2.4 Checkpoints blockade monoclonal antibodies
- 3.3 Classic delivery systems for monoclonal antibodies